Patient: CO Clinicopathologic Conference (CPC) Friday, October 2 nd, 2015 Neurology Resident: C. Chauncey Spears Pathologist: Drs. Wiley and Murdoch.

Slides:



Advertisements
Similar presentations
JCAHO EXPECTATIONS FOR PRIMARY STROKE CENTER
Advertisements

Stroke Workshop Case Scenario.
Advancing the Vision of the Neurological Institute Patient Experience 2014 Julie Fussner BSN, RN, CPHQ, SCRN Advancing the Vision of the Neurological Institute.
Some Difficult Stroke Cases: What Would You Do?
B.A.P.E.T Brain Attack Protocol & Emergency Treatment By: Nicole Florentine, Christina Lauderman Erin Patrick, & Kara Sharp.
TPA… SMART or not SMART? That is the Question. Sarah Parker, MD.
Hyperacute Stroke Treatment: Inclusion and Exclusion Criteria
STROKESTROKESTROKESTROKE. Why Change? Improve Mortality Improve Mortality Devastating and Life Altering Devastating and Life Altering Cost expense of.
Scott Silvers, MD, FACEP Treating ED Ischemic Stroke Patients: NIHSS Approximation & Elevated BP Management.
Edward P. Sloan, MD, MPH ED Stroke Patient Management: What must we be able to do in order to provide tPA in the ED (mimickers, stroke scales, and CT interpretation)?
Prophylaxis of Venous Thromboembolism
Acute Stroke Evaluation Gabriel A. Vidal, MD Vascular Neurology Ochsner Medical Center October 14 th, 2009.
An Overview of Head Injury Management Eldad J. Hadar, M.D. Department of Neurosurgery.
Anticoagulation in Acute Ischemic Stroke. TPA: Tissue Plasminogen Activator 1995: NINDS study of TPA administration Design: randomized, double blind placebo-controlled.
Brain Single-Photon Emission CT With HMPAO and Safety of Thrombolytic Therapy in Acute Ischemic Stroke Proceedings of the Meeting of the SPECT Safe Thrombolysis.
Clinical diagnosis in the acute phase of stroke – quite a challenge! Peter Sandercock Edinburgh.
Scott Silvers, MD, FACEP Treating ED Ischemic Stroke Patients: NIHSS Approximation & Elevated BP Management.
Neuroimaging of Ischemic Stroke With CT and MRI
Case Study Nima Aghaebrahim, 2013 Patterson, James
FERNE/EMRA The Management of ED TIA Patients: What is the optimal outpatient work-up, treatment and disposition?
Clinical Use of tPA in Acute Ischemic Stroke. Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
Stroke Quality Measures Kathy Wonderly RN, BSPA, CPHQ Performance Improvement Coordinator Developed: May, 2012 Most recently updated: October,
Dr Kneale Metcalf Stroke Physician (NNUHFT)
NYU Medical Grand Rounds Clinical Vignette Jennifer Lue, MD PGY-2 9/11/2012 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
Early decompressive surgery for stroke
Malignant MCA Infarction and Hemicraniectomy
European Stroke intervention Guidelines ESMINT/ESO/ESNR/EAN WLNC 2015
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Brief Protocol Training NIH-NINDS U01 NS NETT CCC U01 NS NETT SDMC U01 NS
Stroke and the ED Kurian Thomas, MD Department of Neurology.
The Evolving Management of Pediatric Stroke Christopher A. Miller, MD July 21, 2012.
Morning Report August 7, 2012 Good Morning. Chorea **Show video**
Overview of new acute stroke trials Shawna Cutting, MD, MS Rush University Medical Center June 9, 2015.
The Stroke Oxygen Supplementation PILOT Study C. Roffe, K.Ali, A. Warusevitane, S. Sills, S. Pountain, P Jones, R Gray, P. Crome North Staffordshire Combined.
Intra - Arterial Thrombolysis for acute stroke
OSCE Question 02/2015 TMH AED.
Treatment of Ischaemic Stroke The American Heart Association American Stroke Association Guidelines Stroke. 2007;38:
Simple CBF grading based on MR perfusion to anticipate long-term clinical outcome in severe stroke patients due to the carotid artery occlusion Mori T,
VCU DEATH AND COMPLICATIONS CONFERENCE. Introduction of Case  Complication Death  Procedure  Ex. Lap, Splenectomy, Left anterior thoracotomy, Ligation.
Recognition and Treatment of Large MCA Strokes Matthew S. Smith, MD, MS Director of Neurocritical Care Assistant Professor of Neurology Assistant Professor.
Dr. Meg-angela Christi M. Amores
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Clinical Use of tPA in Acute Ischemic Stroke Edward P. Sloan, MD, MPH Associate Professor Department of Emergency Medicine University of Illinois College.
before thrombolysis in acute stroke
Protocol Nichol McBee, MPH, CCRP BIOS Coordinating Center Johns Hopkins University.
Brain waves or brain drain Interactive case discussion Dr Jenny Vaughan and Dr Richard Perry Charing Cross Hospital Hammersmith Hospital Imperial College.
ACUTE TREATMENT OF STROKE: RECENT ADVANCES AND PERFORMANCE AT CAMPBELLTOWN ALEX BUTTFIELD ED STAFF SPECIALIST.
ACUTE STROKE TREATMENT: An introduction Dec.2014
Atrial Fibrillation Jay H. Lee, MD Denver Health Medical Center Wednesday 2 July 2008.
Management of Acute ISCHEMIC stroke
Hemicraniectomy in Older Patients with Extensive Middle-Cerebral-Artery Stroke DESTINY II TRIAL Katherine Steele 7 April 2014.
Risk Stratification of Chest Pain: Best Practices
CPC 6/3/2016.
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
Direct catheter-based thrombectomy in acute ischemic stroke
PATIENT CASE REPORT Acute Ischemic Stroke Follow-up
Thrombectomy in Acute Stroke
Brian Cristiano, MD; M. Pond, MD; R. Nowrangi, MD MPH; S. Basu, MD; U
Guide on how to manage atrial fibrillation in the office
When Not to Intervene in Acute Stroke or
Morbidity and Mortality Conference
Setareh Omran, MD Vascular Neurology Fellow
Update from education committee
Performance Improvement: Emergency Management in Acute Cerebrovascular Patients Current US Guidelines Lisa A. Shultz, MD Medical Director, Lourdes Stroke.
Etiology of stroke Sanjeeva Onteddu.
Guidelines for Urgent Management of Stroke in Children
TIA/Stroke (1) C.L.I.P.S. Why do we care?
Extended Window Thrombectomy
Update from education committee
A 92-year-old man presented with left hemiparesis, dysarthria, hemianopia and inattention National Institutes of Health Stroke Scale (NIHSS) 19. A 92-year-old.
Presentation transcript:

Patient: CO Clinicopathologic Conference (CPC) Friday, October 2 nd, 2015 Neurology Resident: C. Chauncey Spears Pathologist: Drs. Wiley and Murdoch

History – ED 935am, 9/5/15 CO is a 39yo Kenyan born man with no known medical problems or stroke risk factors who presented on 9/5/15 after being involved in a low speed MVA at work with notice of R gaze deviation + L-sided hemiplegia thereafter; LSW 830am / mRS 0. VS ok. (SBP < 185) Acute stroke labs ok. (Hb, Plts, BUN:Cr, Glu, INR, trp) NIH 14 (1 R gaze, 2 L FP, 3 LUE, 3 LLE, 1 L sens, 2 Dysarthria, 2 L Ext/Neglect)

CTH / 945am, 9/5/15 [ASPECT ?]

CTH / 945am, 9/5/15

Mechanism?

Treatment?

Hospital Course IV 1023am  NIH 14 Mechanical 1130am  NIH 10 to 12

Hospital Course 5pm  NIH 15-18, less awake + weaker on L 6pm MRI Brain

Hospital Course 10am continued poor LOC

Uh Oh?!?

UPMC Hemicrani Protocol Lancet Neurology, 2007; 6:

UPMC Hemicrani Protocol Eligibility criteria For prophylactic decompression (ie, decompression prior to clinical worsening) – Age 18 – 70 years without evidence of significant pre-existing co-morbidities – Clinical deficits suggestive of infarction in the territory of the MCA with a score on the National Institutes of Health stroke scale (NIHSS) >12 for dominant hemisphere, > 10 for non-dominant. – Stroke volume >180 ml For early therapeutic decompression (ie, within 48 hours of admission) – Age 18–60 years, > 60 years may be considered based on the absence of co-morbidities and level of function – Clinical deficits suggestive of infarction in the territory of the MCA with a score on the National Institutes of Health stroke scale (NIHSS) >12 for dominant hemisphere, > 10 for non-dominant. – Decrease in the level of consciousness to a score of 1 (ie, not alert, but arousable with minimal stimulation) or greater on item 1a of the NIHSS. – Signs on CT or MRI (preferred) of an infarct involving a stroke volume of > 150ml. Exclusion criteria Absolute contraindications – Pre-stroke score on the mRS ≥ 3 Two fixed dilated pupils GCS < 4 without improvement in the first 24 hours Known irreversible coagulopathy or systemic bleeding disorder Relative contraindications – Complete ICA distribution ischemia on affected side Contralateral ischemia or other brain lesion that could affect outcome Medical co-morbidities that impact on life expectancy Other serious illness that could affect outcome

Hospital Course 1pm  Hemicraniectomy

Hospital Course 4pm (post op)  NIH 29 (intubated) 9/7  NIH after self extubation 9/7 to 9/15  NIH 12 Stroke Work-up EKG 1 st deg AV block, Trp neg TTE w WF 70%, mild L>R shunt, Mod Pulm HTN TEE with B/L Atrial enlargement, No cardiac source of emboli LDL 65 A1c 6.2 UDS/ETOH neg Hypercoag screening with weak, non dx LAC; Neg otherwise DISCHARGED TO REHAB 9/15!!!

Hospital Course …. 945am while supine CONDITION C dizziness, syncope x 30sec  CP, Diaphoresis, Sinus tachy, TWI in V2 Transferred to Inpt but first to CT Scanner…

Hospital Course Condition A in CT GTC Seizure (2mg ativan) Pulseless Arrest, EKG STEMI Anterior Leads -Chest compressions x 50min -Epi (> 20) -Vasopressin 40u -Calcium Gluconate x4 -Bicarb x5 -Bedside Echo = no cardiac wall motion Time of Death = 1130am

Autopsy Large, acute pulmonary emboli occluding R and L main pulmonary arteries. No A-V shunt Neuropath …… *Of note, patient was receiving daily therapy with ASA 81mg + sc hep at 5000iu q8h throughout rehab stay.

Predicted Pathology?

Predicted Pathology